Hints and tips:
Related Special Reports
...Glenn Fogel, who runs the US global group as well as its biggest subsidiary Amsterdam-based Booking.com, said that regulators should think twice before stopping deals that would make “the European tech ecosystem...
...“The IPO has engaged with stakeholders as part of a working group with the aim of agreeing a voluntary code on AI and copyright,” a government spokesperson said....
...Glenn Fogel, the company’s chief executive, has in the past hit out at the EU’s plans to regulate it as a “gatekeeper”, arguing that fresh regulatory burdens would “handcuff” it and restrain its ability...
...The Development Bank of Japan is investing in 4Bio, which funds companies in the UK and Europe, alongside the Japanese pharma group Kyowa Kirin, and US healthcare provider, Children’s Minnesota. 4Bio aims...
...Such pledges have been made in other industries such as technology, with software groups offering not to enforce their rights to help facilitate the development of open source platforms....
...A spokesperson for the regional court in Düsseldorf, in western Germany, said it had found for the litigants, R2 Semiconductor, a technology group based in Palo Alto, California, against Intel....
...On the other, telecoms groups, such as Qualcomm and Nokia, that invented and control the standard essential patents, or SEPs, which allow all kinds of gadgets to access the 5G and Wi-Fi networks that they...
...In a slick video posted on social media earlier this year, Virginia’s Republican governor Glenn Youngkin contemplates America’s future....
...It faced patent expiries on several former blockbuster medicines; its pipeline was weak....
...That gives SenseTime’s generative AI segment, which tripled last year and accounted for more than a third of group revenue, some income back-up from the group’s other business units....
...But with a HIV patent set to expire in 2028, a fifth of GSK’s sales were exposed to patent cliffs by the end of 2030, according to Bank of America analyst Graham Parry....
...He adds that designer Glenn Martens has excelled in creating “intelligible fashion concepts that are more democratic”....
...The toy retailer started life in 1901 in Liverpool when founder Frank Hornby received a patent for his Meccano construction toy....
...It is summer, and Glenn Fogel is planning a trip. The itinerary is simple: he’ll fly from the US to Amsterdam, meet his wife, who has been touring Europe, and spend the weekend in Belgium....
...PGIA, the US division of Australia’s Perpetual, filed for similar relief in February last year, even before the May expiry of Vanguard’s 22-year patent on the structure....
...Credible challengers like Virginia’s Reaganite governor Glenn Youngkin showed how to win back moderate Democrats....
...Elsewhere, however, the group has made progress. In South Africa, Dabus has been listed as the inventor on a patent and Australia’s Federal Court has ruled that Dabus can also be an inventor....
...While big pharma companies focus on developing innovative drugs that they can sell under patent and at high margins, recouping research and development costs, off-patent generic medicines such as methotrexate...
...The problem for Novo is that its patent for Wegovy in China is due to expire in 2026. For sure, analysts still expect strong sales growth....
...PGIA, the US division of Australia’s Perpetual, filed for similar relief in February, even before the May sunset of Vanguard’s 22-year patent on the structure....
...Huawei has sealed a multiyear patent cross-licensing deal with Ericsson for 5G and other technologies as the Chinese group searches for ways to generate revenue after being banned from telecom networks or...
...who is a member of ART SG’s 26-person advisory group....
...On the other, the telecoms groups that invented and control the “standard essential patents”, which allow all kinds of gadgets to access the 5G and WiFi networks that they need to work....
...The company also faces the expiration of key patents in its pharma division and last year aborted a late-stage trial of its most hopeful new drugs....
...Moderna alleges that Pfizer and BioNTech infringed on two of its patents in their use of the critical mRNA platform. BioNTech and Pfizer say the patents are invalid....
International Edition